Background: Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature. Main body: This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort. Short conclusion: We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice.
CITATION STYLE
Parente, L. (2017). Deflazacort: Therapeutic index, relative potency and equivalent doses versus other corticosteroids. BMC Pharmacology and Toxicology, 18(1). https://doi.org/10.1186/s40360-016-0111-8
Mendeley helps you to discover research relevant for your work.